跳至主要内容
临床试验/NCT03193541
NCT03193541招募中不适用

A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer

Cedars-Sinai Medical Center14 个研究点 分布在 2 个国家目标入组 900 人开始时间: 2016年12月30日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
900
试验地点
14
主要终点
Sensitivity and specificity of multiplex ELISA assay will be confirmed by cystoscopy.

研究概览

简要总结

To improve upon the non-invasive detection of BCa by further validating a multiplex ELISA assay directed at a BCa-associated diagnostic signature in voided urine samples of patients with microscopic hematuria.

详细描述

Hematuria is the most common presentation of BCa with 8% of patients with microscopic hematuria harboring BCa. VUC is the most widely used urine-based assay for detecting BCa; however, it fails to detect approximately 50% of low-grade or early stage BCa when it is most curable. Because of this severe limitation, patients with hematuria will undergo an invasive examination of the urinary bladder, where a miniature camera is inserted into the bladder.

We propose to improve the non-invasive detection of BCa by further validating a multiplex ELISA assay directed at a BCa-associated diagnostic signature in voided urine samples of patients with microscopic hematuria.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years or older
  • Have documented or reported microscopic hematuria within 3 month of study enrollment
  • Willing and able to give written informed consent

排除标准

  • (participants must not):
  • Have history of BCa
  • History of previous cancer (excluding basal and squamous cell skin cancer)
  • Have a known active urinary tract infection or urinary retention
  • Have active stone disease (renal or bladder) or renal insufficiency (creatinine >2.0 mg/dL)
  • Have ureteral stents, nephrostomy tubes or bowel interposition
  • Have recent genitourinary instrumentation (within 10 days prior to signing consent)
  • Be unable or unwilling to complete the hematuria evaluation (i.e., cystoscopy and upper tract imaging)

结局指标

主要结局

Sensitivity and specificity of multiplex ELISA assay will be confirmed by cystoscopy.

时间窗: 1 year

次要结局

  • Sensitivity and specificity of multiplex ELISA assay will be compared to VUC and NMP-22 BladderChek.(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Charles Rosser

Professor

Cedars-Sinai Medical Center

研究点 (14)

Loading locations...

相似试验